Orquín OE, Agüera CJ, Velasco GMÁ, Vega RV

Language: Spanish
References: 19
Page: 12-16
PDF size: 62.79 Kb.

ABSTRACT

Introduction: breast cancer in the Western society has the highest prevalence rate in females, but it is very rare in males (0.1-0.2 %). After analyzing the epidemiology and the risk factors, a retrospective study was conducted on the cases found in an outpatient minor surgery unit of "Juan Grande" general hospital of medical specialties in the period of 1990 through 2011 (n=10).
Methods: the findings observed in this unit were described, where patients with benign disease diagnoses fundamentally went because of skin problems, cutaneous adnexes and subcutaneous tissues. The males suffering breast carcinoma were selected, described and followed-up. Inclusion criteria were being male and histological confirmation of breast cancer. The epidemiological, tumoral and therapeutical variables were under study as well as survival rates.
Results: there were 10 individuals aged 58 ± 15 years, with no history of special interest. Tumors were located in the anterior side of thorax, unilateral, in the breast region. One hundred percent of patients went to the unit with benign diagnosis and, the final anatomopathological diagnosis of all the cases was ductal carcinoma.
Conclusions: the patients were diagnosed after one surgery and there was not previous clinical diagnosis. The survival depended on the time of diagnosis and on the time of beginning the treatment. The survival rate after 5 years of review was 7 patients, although some died from other causes.

REFERENCES

1. Zapardiel I, Aznar F, De la Fuente-Valero J. Cáncer de mama I. Editorial SAEGO, 2009; Capt 40: 493-511.

2. Díaz-Faes J. Cáncer de mama del varón. ¿Es la misma enfermedad que el cáncer de mama de mujer? Oncología. 1999;22(4):17-18.

3. Elshafiey MM, Zeeneldin AA, Elsebai HI, Moneer M, Mohamed DB, Gouda I, Attia AA. Epidemiology and management of breast carcinoma in Egyptian males: Experience of a single Cancer Institute. J Egypt Natl Canc Inst. 2011;23(3):115-22.

4. Dabakuyo TS, Dialla O, Gentil J, Poillot ML, Roignot P, Cuisenier J, Arveux P. Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors. Eur J Cancer Care (Engl). 2012 May 30. doi: 10.1111/j.1365 2354.2012.01365.x. Epub 2012 May 30

5. Kao L, Bulkin Y, Fineberg S, Montgomery L, Koenigsberg T. A case report: lobular carcinoma in situ in a male patient with subsequent invasive ductal carcinoma identified on screening breast MRI. J Cancer. 2012;3:226-30.

6. Aguilar-Luque J, Sarmiento-Robles C, Merino-delaTorre E, Martínez-García P. Carcinoma de mama del varón. Análisis de 5 casos y revisión bibliográfica. Rev. Cubana Oncol. 2001;17(2):128-34.

7. Pemmaraju N, Munsell MF, Hortobagyi GN, Giordano SH. Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects. Ann Oncol. 2012 Jun;23(6):1471-4.

8. Saleh N, Amir T, Shafi IN. Mammary fibromatosis in a male breast. Gulf J Oncolog. 2012;1(12):77-80.

9. Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, Hinrichs B, van Diest PJ. Fibrotic focus and hypoxia in male breast cancer. Mod Pathol. 2012; doi: 10.1038/modpathol.2012.101 Epub 2012 Jun 8.

10. Bacha D, Ayadi-Kaddour A, Kchaou S, Chaabene M, El Mezni F. Fibromatosis of the breast in a male patient. Tunis Med. 2011 Aug-Sep;89(8-9):727-8.

11. Waugh E, Baeza R, Leon A. Tratamiento de cáncer de mama en los hombres. Rev Med Chil. 1995;123(7):830-2.

12. Fidan E, Yildiz B, Ersoz S, Ozdemir F. Bilateral breast cancer: a male patient. Bratisl Lek Listy. 2011;112(10):589-90. PMID: 21954546.

13. Tallón-Aguilar L, Serrano-Borrero I, López-Porras M, Sousa-Vaquero JM, de León-Carrillo J. Breast cancer in males. Cir Cir. 2011 Jul-Aug;79(4):296-8.

14. Xia Q, Shi YX, Liu DG, Jiang WQ. Clinicopathological characteristics of male breast cancer: analysis of 25 cases at a single institution. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Sep;31(9):1469-73.

15. Villeneuve S, Cyr D, Lynge E, Orsi L, Sabroe S, Merletti F,et al. Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe. Occup Environ Med. 2010 Dec;67(12):837-44.

16. Duggleby W, Bally J, Cooper D, Doell H, Thomas R. Engaging hope: the experiences of male spouses of women with breast cancer. Oncol Nurs Forum. 2012;39(4):400-6.

17. Kornegoor R, Moelans CB, Verschuur-Maes AH, Hogenes MC, de Bruin PC, Oudejans JJ, et al. Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification. Breast Cancer Res Treat. 2012; 13.

18. Schiffman SC, Chagpar AB. Does a family history of male breast cancer influence risk perception and use of genetic testing? Am Surg. 2010 Aug;76(8):879-82.

19. Treviño M, Jandorf L, Bursac Z, Erwin DO. Cancer screening behaviors among Latina women: the role of the Latino male. J Community Health. 2012 Jun;37(3):694-700.